Long-term oncologic outcomes of radiotherapy combined with maximal androgen blockade for localized, high-risk prostate cancer

被引：0
|
作者：
Yong Luo
Mingchuan Li
Hengzhi Qi
Jiahui Zhao
Yili Han
Yunhua Lin
Zhu Hou
Yongguang Jiang
机构：
[1] Capital Medical University,Department of Urology, Beijing Anzhen Hospital
来源：
World Journal of Surgical Oncology | / 16卷
关键词：
Prostate cancer; Brachytherapy; PSA kinetics; Maximal androgen blockade; Radiation therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Long-term oncologic outcomes of radiotherapy combined with maximal androgen blockade for localized, high-risk prostate cancer
    Luo, Yong
    Li, Mingchuan
    Qi, Hengzhi
    Zhao, Jiahui
    Han, Yili
    Lin, Yunhua
    Hou, Zhu
    Jiang, Yongguang
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2018, 16
  • [2] Adherence to Long-term Androgen Blockade in Localized High-Risk Prostate Cancer and Causes of Noncompliance
    Nabid, A.
    Carrier, N.
    Martin, A.
    Bahary, J.
    Duclos, M.
    Vincent, F.
    Vass, S.
    Bahoric, B.
    Archambault, R.
    Lemaire, C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S374 - S375
  • [3] Long-term combined androgen blockade alone for localized prostate cancer
    Labrie, F
    Cusan, L
    Gomez, JL
    Belanger, A
    Candas, B
    [J]. MOLECULAR UROLOGY, 1999, 3 (03) : 217 - 225
  • [4] Very high-risk prostate cancer: stratification by outcomes of radiotherapy and long-term androgen deprivation therapy
    Tomita, Natsuo
    Soga, Norihito
    Ogura, Yuji
    Kageyama, Takumi
    Kodaira, Takeshi
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (03) : 145 - 151
  • [5] Patient Reported Outcomes after Hypofractionated Radiotherapy and Long-term Androgen Deprivation for High-risk Prostate Cancer
    Quon, H. C.
    Loblaw, D. A.
    Morton, G.
    Szumacher, E.
    Danjoux, C.
    Choo, R.
    Thomas, G.
    Kiss, A.
    Deabreu, A.
    Cheung, P. C. F.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S345 - S345
  • [6] HDR Boost Combined With Short-term Androgen Blockade Produces Excellent Long-term Outcome in High-Risk Prostate Cancer
    Hayes, J. K.
    Hansen, R. S.
    Rogers, C. L.
    Stephenson, R. A.
    Gange, S. N.
    Swallow, C. T.
    Alder, S. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S402 - S402
  • [7] Long-term outcomes of combined androgen blockade therapy in stage IV prostate cancer
    Matsuoka, Taeko
    Kawai, Koji
    Kimura, Tomokazu
    Kojima, Takahiro
    Onozawa, Mizuki
    Miyazaki, Jun
    Nishiyama, Hiroyuki
    Hinotsu, Shiro
    Akaza, Hideyuki
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (04) : 759 - 765
  • [8] Long-term outcomes of combined androgen blockade therapy in stage IV prostate cancer
    Taeko Matsuoka
    Koji Kawai
    Tomokazu Kimura
    Takahiro Kojima
    Mizuki Onozawa
    Jun Miyazaki
    Hiroyuki Nishiyama
    Shiro Hinotsu
    Hideyuki Akaza
    [J]. Journal of Cancer Research and Clinical Oncology, 2015, 141 : 759 - 765
  • [9] Long-term outcomes of 60 gy conventional radiotherapy combined with androgen deprivation for localized or locally advanced prostate cancer
    Hashine, K
    Numata, K
    Azuma, K
    Sumiyoshi, Y
    Kataoka, M
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 35 (11) : 655 - 659
  • [10] Even high-dose radiotherapy requires long-term androgen ablation for high-risk prostate cancer
    Nam, T. K.
    Kwon, D. D.
    Jeong, J. W.
    Kim, Y. H.
    Yoon, M. S.
    Song, J. Y.
    Ahn, S. J.
    Chung, W. K.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S346 - S346
12345